首页 > 最新文献

Seminars in Vascular Surgery最新文献

英文 中文
Emergent endovascular treatment options for thoracoabdominal aortic aneurysm 胸腹主动脉瘤急诊血管内治疗方案
IF 2.5 3区 医学 Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1053/j.semvascsurg.2023.04.004
Alessandro Grandi , Andrea Melloni , Mario D'Oria , Sandro Lepidi , Stefano Bonardelli , Tilo Kölbel , Luca Bertoglio

For a long time, parallel grafting, physician-modified endografts, and, more recently, in situ fenestration were the only go-to endovascular options for ruptured thoracoabdominal aortic aneurysm, offered mixed results, and depended mainly on the operator's and center's experience. As custom-made devices have become an established endovascular treatment option for elective thoracoabdominal aortic aneurysm, they are not a viable option in the emergency setting, as endograft production can take up to 4 months. The development of off-the-shelf (OTS) multibranched devices with a standardized configuration has allowed the treatment of ruptured thoracoabdominal aortic aneurysm with emergent branched endovascular procedures. The Zenith t-Branch device (Cook Medical) was the first readily available graft outside the United States to receive the CE mark (in 2012) and is currently the most studied device for those indications. A new device, the E-nside thoracoabdominal branch endoprosthesis OTS multibranched endograft (Artivion), has been made commercially available, and the GORE EXCLUDER thoracoabdominal branch endoprosthesis OTS multibranched endograft (W. L. Gore and Associates) is expected to be released in 2023. Due to the lack of guidelines on ruptured thoracoabdominal aortic aneurysm, this review summarizes the available treatment options (ie, parallel grafts, physician-modified endografts, in situ fenestrations, and OTS multibranched devices), compares the indications and contraindications, and points out the evidence gaps that should be filled in the next decade.

长期以来,平行移植、医生改良的内移植物,以及最近的原位开窗术,是治疗胸腹主动脉瘤破裂的唯一血管内选择,结果喜忧参半,主要取决于操作员和中心的经验。由于定制装置已成为选择性胸腹主动脉瘤的血管内治疗选择,因此在紧急情况下它们不是一个可行的选择,因为内移植物的生产可能需要长达4个月的时间。具有标准化配置的现成(OTS)多分支装置的开发允许通过紧急分支血管内手术治疗破裂的胸腹主动脉瘤。Zenith t分支装置(Cook Medical)是美国以外第一个获得CE标志的现成移植物(2012年),也是目前针对这些适应症研究最多的装置。一种新的设备,E-nside胸腹支内假体OTS多支内移植物(Artivion),已经上市,GORE EXCLUDER胸腹支外假体OTS多支内移动物(W.L.GORE and Associates)预计将于2023年发布。由于缺乏关于胸腹主动脉瘤破裂的指南,本综述总结了可用的治疗方案(即平行移植物、医生改良的内移植物、原位开窗术和OTS多分支装置),比较了适应症和禁忌症,并指出了未来十年应填补的证据空白。
{"title":"Emergent endovascular treatment options for thoracoabdominal aortic aneurysm","authors":"Alessandro Grandi ,&nbsp;Andrea Melloni ,&nbsp;Mario D'Oria ,&nbsp;Sandro Lepidi ,&nbsp;Stefano Bonardelli ,&nbsp;Tilo Kölbel ,&nbsp;Luca Bertoglio","doi":"10.1053/j.semvascsurg.2023.04.004","DOIUrl":"10.1053/j.semvascsurg.2023.04.004","url":null,"abstract":"<div><p>For a long time, parallel grafting, physician-modified endografts, and, more recently, in situ fenestration were the only go-to endovascular options for ruptured thoracoabdominal aortic aneurysm, offered mixed results, and depended mainly on the operator's and center's experience. As custom-made devices have become an established endovascular treatment option for elective thoracoabdominal aortic aneurysm, they are not a viable option in the emergency setting, as endograft production can take up to 4 months. The development of off-the-shelf (OTS) multibranched devices with a standardized configuration has allowed the treatment of ruptured thoracoabdominal aortic aneurysm with emergent branched endovascular procedures. The Zenith t-Branch device (Cook Medical) was the first readily available graft outside the United States to receive the CE mark (in 2012) and is currently the most studied device for those indications. A new device, the E-nside thoracoabdominal branch endoprosthesis OTS multibranched endograft (Artivion), has been made commercially available, and the GORE EXCLUDER thoracoabdominal branch endoprosthesis OTS multibranched endograft (W. L. Gore and Associates) is expected to be released in 2023. Due to the lack of guidelines on ruptured thoracoabdominal aortic aneurysm, this review summarizes the available treatment options (ie, parallel grafts, physician-modified endografts, in situ fenestrations, and OTS multibranched devices), compares the indications and contraindications, and points out the evidence gaps that should be filled in the next decade.</p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9715284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Major vascular traumas to the neck, upper limbs, and chest: Clinical presentation, diagnostic approach, and management strategies 颈部、上肢和胸部的主要血管损伤:临床表现、诊断方法和治疗策略
IF 2.5 3区 医学 Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1053/j.semvascsurg.2023.04.010
Giovanni Badalamenti , Ciro Ferrer , Cristiano Calvagna , Marco Franchin , Gabriele Piffaretti , Jacopo Taglialavoro , Silvia Bassini , Filippo Griselli , Beatrice Grando , Sandro Lepidi , Mario D'Oria

Major vascular traumas to the neck, upper limbs, and chest may arise from penetrating and/or blunt mechanisms, resulting in a range of clinical scenarios. Lesions to the carotid arteries may also lead to neurologic complications, such as stroke. The increasing use of invasive arterial access for diagnostic and/or interventional purposes has increased the rate of iatrogenic injuries, which usually occur in older and hospitalized patients. Bleeding control and restoration of perfusion represent the two main goals of treatment for vascular traumatic lesions. Open surgery still represents the gold standard for most lesions, although endovascular approaches have increasingly emerged as feasible and effective options, particularly for management of subclavian and aortic injuries. In addition to advanced imaging (including ultrasound, contrast-enhanced cross-sectional imaging, and arteriography) and life support measures, multidisciplinary care is required, particularly in the setting of concomitant injuries to the bones, soft tissues, or other vital organs. Modern vascular surgeons should be familiar with the whole armamentarium of open and endovascular techniques needed to manage major vascular traumas safely and promptly.

颈部、上肢和胸部的主要血管创伤可能由穿透和/或钝性机制引起,导致一系列临床情况。颈动脉损伤也可能导致神经系统并发症,如中风。越来越多地使用侵入性动脉通路进行诊断和/或介入,增加了医源性损伤的发生率,这种损伤通常发生在老年和住院患者中。控制出血和恢复灌注是血管损伤治疗的两个主要目标。开放手术仍然是大多数病变的金标准,尽管血管内方法越来越成为可行和有效的选择,特别是在锁骨下和主动脉损伤的治疗中。除了高级成像(包括超声、增强横截面成像和动脉造影)和生命支持措施外,还需要多学科护理,尤其是在骨骼、软组织或其他重要器官同时受伤的情况下。现代血管外科医生应该熟悉安全、及时地处理重大血管创伤所需的开放和血管内技术的全部知识。
{"title":"Major vascular traumas to the neck, upper limbs, and chest: Clinical presentation, diagnostic approach, and management strategies","authors":"Giovanni Badalamenti ,&nbsp;Ciro Ferrer ,&nbsp;Cristiano Calvagna ,&nbsp;Marco Franchin ,&nbsp;Gabriele Piffaretti ,&nbsp;Jacopo Taglialavoro ,&nbsp;Silvia Bassini ,&nbsp;Filippo Griselli ,&nbsp;Beatrice Grando ,&nbsp;Sandro Lepidi ,&nbsp;Mario D'Oria","doi":"10.1053/j.semvascsurg.2023.04.010","DOIUrl":"10.1053/j.semvascsurg.2023.04.010","url":null,"abstract":"<div><p>Major vascular traumas to the neck, upper limbs, and chest may arise from penetrating and/or blunt mechanisms, resulting in a range of clinical scenarios. Lesions to the carotid arteries may also lead to neurologic complications, such as stroke. The increasing use of invasive arterial access for diagnostic and/or interventional purposes has increased the rate of iatrogenic injuries, which usually occur in older and hospitalized patients. Bleeding control and restoration of perfusion represent the two main goals of treatment for vascular traumatic lesions. Open surgery still represents the gold standard for most lesions, although endovascular approaches have increasingly emerged as feasible and effective options, particularly for management of subclavian and aortic injuries. In addition to advanced imaging (including ultrasound, contrast-enhanced cross-sectional imaging, and arteriography) and life support measures, multidisciplinary care is required, particularly in the setting of concomitant injuries to the bones, soft tissues, or other vital organs. Modern vascular surgeons should be familiar with the whole armamentarium of open and endovascular techniques needed to manage major vascular traumas safely and promptly.</p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9715752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Emergency vascular surgical care in populations with unique physiologic characteristics: Pediatric, pregnant, and frail populations 具有独特生理特征人群的急诊血管外科护理:儿科、孕妇和虚弱人群
IF 2.5 3区 医学 Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1053/j.semvascsurg.2023.04.015
David Warner , Kathryn W. Holmes , Rana Afifi , Melissa L. Russo , Sherene Shalhub

Vascular surgical emergencies are common in vascular surgical care and require complex decision making and multidisciplinary care. They are especially challenging when they occur in patients with unique physiological characteristics, such as pediatric, pregnant, and frail patients. Among the pediatric and pregnant population, vascular emergencies are rare. This rarity challenges accurate and timely diagnosis of the vascular emergency. This landscape review summarizes these three unique populations' epidemiology and emergency vascular considerations. Understanding the epidemiology is the foundation for accurate diagnosis and subsequent management. Considering each population's unique characteristics is crucial to the emergent vascular surgical interventions decision making. Collaborative and multidisciplinary care is vital in gaining expertise in managing these special populations and achieving optimal patient outcomes.

血管外科紧急情况在血管外科护理中很常见,需要复杂的决策和多学科护理。当它们发生在具有独特生理特征的患者身上时,尤其具有挑战性,如儿科、孕妇和体弱患者。在儿科和孕妇人群中,血管紧急情况很少见。这种罕见的情况对血管紧急情况的准确和及时诊断提出了挑战。这篇综述总结了这三个独特人群的流行病学和紧急血管注意事项。了解流行病学是准确诊断和后续管理的基础。考虑每个人群的独特特征对于紧急血管外科干预决策至关重要。协作和多学科护理对于获得管理这些特殊人群的专业知识和实现最佳患者结果至关重要。
{"title":"Emergency vascular surgical care in populations with unique physiologic characteristics: Pediatric, pregnant, and frail populations","authors":"David Warner ,&nbsp;Kathryn W. Holmes ,&nbsp;Rana Afifi ,&nbsp;Melissa L. Russo ,&nbsp;Sherene Shalhub","doi":"10.1053/j.semvascsurg.2023.04.015","DOIUrl":"10.1053/j.semvascsurg.2023.04.015","url":null,"abstract":"<div><p><span>Vascular surgical emergencies are common in vascular surgical care and require complex decision making and multidisciplinary care. They are especially challenging when they occur in patients<span> with unique physiological characteristics, such as pediatric, pregnant, and frail patients. Among the pediatric and pregnant population, vascular emergencies are rare. This rarity challenges accurate and timely diagnosis of the vascular emergency. This landscape review summarizes these three unique populations' </span></span>epidemiology and emergency vascular considerations. Understanding the epidemiology is the foundation for accurate diagnosis and subsequent management. Considering each population's unique characteristics is crucial to the emergent vascular surgical interventions decision making. Collaborative and multidisciplinary care is vital in gaining expertise in managing these special populations and achieving optimal patient outcomes.</p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9662174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe local wound infections after vascular exposure in the groin and other body areas: Prevention, treatment and prognosis 腹股沟和其他身体部位血管暴露后的严重局部伤口感染:预防、治疗和预后
IF 2.5 3区 医学 Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1053/j.semvascsurg.2023.04.014
Marta Minucci , Tommaso Donati , Antonio Luparelli, Lucia Scurto, Julia Paolini, Simona Sica, Marco Natola, Fabrizio Minelli, Yamume Tshomba, Giovanni Tinelli

Severe surgical site infections (SSIs) are a frequent nosocomial complication after vascular interventions, an important cause of postoperative morbidity, and a substantial burden to the health care system. Patients undergoing arterial interventions are at elevated risk of SSIs, possibly because of the presence of several risk factors in this patient population. In this review, we examined the available clinical evidence for the prevention, treatment, and prognostication of postoperative severe SSIs after vascular exposure in the groin and other body areas. Results from studies evaluating preoperative, intraoperative, and postoperative preventive strategies and several treatment options are reviewed. In addition, risk factors for surgical wound infections are analyzed in detail and related evidence from the literature is highlighted. Although several measures have been implemented over the time to prevent them, SSIs continue to pose a substantial health care and socioeconomic challenge. Therefore, strategies to decrease the risk and improve the treatment of SSIs for the high-risk vascular patient population should be the focus of continuing improvement and critical review. This review aimed at identifying and reviewing the current evidence for preventing, treating, and performing stratification according to the prognosis of postoperative severe SSIs after vascular exposure in the groin and other body areas.

严重手术部位感染(SSIs)是血管干预后常见的医院并发症,是术后发病率的重要原因,也是医疗保健系统的巨大负担。接受动脉介入治疗的患者发生SSI的风险较高,可能是因为该患者群体中存在多种风险因素。在这篇综述中,我们研究了腹股沟和其他身体部位血管暴露后术后严重SSIs的预防、治疗和预后的可用临床证据。综述了评估术前、术中和术后预防策略和几种治疗方案的研究结果。此外,对手术伤口感染的危险因素进行了详细分析,并强调了文献中的相关证据。尽管随着时间的推移,已经采取了一些措施来预防SSI,但SSI仍然对医疗保健和社会经济构成重大挑战。因此,降低高危血管患者人群SSIs风险和改善其治疗的策略应成为持续改进和关键审查的重点。本综述旨在确定和审查目前预防、治疗和根据腹股沟和其他身体部位血管暴露后术后严重SSIs的预后进行分层的证据。
{"title":"Severe local wound infections after vascular exposure in the groin and other body areas: Prevention, treatment and prognosis","authors":"Marta Minucci ,&nbsp;Tommaso Donati ,&nbsp;Antonio Luparelli,&nbsp;Lucia Scurto,&nbsp;Julia Paolini,&nbsp;Simona Sica,&nbsp;Marco Natola,&nbsp;Fabrizio Minelli,&nbsp;Yamume Tshomba,&nbsp;Giovanni Tinelli","doi":"10.1053/j.semvascsurg.2023.04.014","DOIUrl":"10.1053/j.semvascsurg.2023.04.014","url":null,"abstract":"<div><p>Severe surgical site infections (SSIs) are a frequent nosocomial complication after vascular interventions, an important cause of postoperative morbidity, and a substantial burden to the health care system. Patients undergoing arterial interventions are at elevated risk of SSIs, possibly because of the presence of several risk factors in this patient population. In this review, we examined the available clinical evidence for the prevention, treatment, and prognostication of postoperative severe SSIs after vascular exposure in the groin and other body areas. Results from studies evaluating preoperative, intraoperative, and postoperative preventive strategies and several treatment options are reviewed. In addition, risk factors for surgical wound infections are analyzed in detail and related evidence from the literature is highlighted. Although several measures have been implemented over the time to prevent them, SSIs continue to pose a substantial health care and socioeconomic challenge. Therefore, strategies to decrease the risk and improve the treatment of SSIs for the high-risk vascular patient population should be the focus of continuing improvement and critical review. This review aimed at identifying and reviewing the current evidence for preventing, treating, and performing stratification according to the prognosis of postoperative severe SSIs after vascular exposure in the groin and other body areas.</p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9662175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mature AI/ML-Enabled Medical Tools Impacting Vascular Surgical Care: A scoping review of late-stage, FDA approved/cleared technologies relevant to vascular surgeons 影响血管外科护理的成熟人工智能/机器学习医疗工具:对后期、FDA批准/清除的血管外科相关技术的范围审查
IF 2.5 3区 医学 Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1053/j.semvascsurg.2023.06.001
David P. Stonko, C. Hicks
Artificial intelligence and machine learning (AI/ML)-enabled tools are shifting from theoretical or research-only applications to mature, clinically useful tools. The goal of this article was to provide a scoping review of the most mature AI/ML-enabled technologies reviewed and cleared by the US Food and Drug Administration relevant to the field of vascular surgery. Despite decades of slow progress, this landscape is now evolving rapidly, with more than 100 AI/ML-powered tools being approved by the US Food and Drug Administration each year. Within the field of vascular surgery specifically, this review identified 17 companies with mature technologies that have at least one US Food and Drug Administration clearance, all occurring between 2016 and 2022. The maturation of these technologies appears to be accelerating, with improving regulatory clarity and clinical uptake. The early AI/ML-powered devices extend or amplify clinically entrenched platform technologies and tend to be focused on the diagnosis or evaluation of time-sensitive, clinically important pathologies (eg, reading Digital Imaging and Communications in Medicine-compliant computed tomography images to identify pulmonary embolism), or when physician efficiency or time savings is improved (eg, preoperative planning and intraoperative guidance). The majority (>75%) of these technologies are at the intersection of radiology and vascular surgery. It is becoming increasingly important that the contemporary vascular surgeon understands this shifting paradigm, as these once-nascent technologies are finally maturing and will be encountered with increasingly regularity in daily clinical practice.
{"title":"Mature AI/ML-Enabled Medical Tools Impacting Vascular Surgical Care: A scoping review of late-stage, FDA approved/cleared technologies relevant to vascular surgeons","authors":"David P. Stonko, C. Hicks","doi":"10.1053/j.semvascsurg.2023.06.001","DOIUrl":"https://doi.org/10.1053/j.semvascsurg.2023.06.001","url":null,"abstract":"Artificial intelligence and machine learning (AI/ML)-enabled tools are shifting from theoretical or research-only applications to mature, clinically useful tools. The goal of this article was to provide a scoping review of the most mature AI/ML-enabled technologies reviewed and cleared by the US Food and Drug Administration relevant to the field of vascular surgery. Despite decades of slow progress, this landscape is now evolving rapidly, with more than 100 AI/ML-powered tools being approved by the US Food and Drug Administration each year. Within the field of vascular surgery specifically, this review identified 17 companies with mature technologies that have at least one US Food and Drug Administration clearance, all occurring between 2016 and 2022. The maturation of these technologies appears to be accelerating, with improving regulatory clarity and clinical uptake. The early AI/ML-powered devices extend or amplify clinically entrenched platform technologies and tend to be focused on the diagnosis or evaluation of time-sensitive, clinically important pathologies (eg, reading Digital Imaging and Communications in Medicine-compliant computed tomography images to identify pulmonary embolism), or when physician efficiency or time savings is improved (eg, preoperative planning and intraoperative guidance). The majority (>75%) of these technologies are at the intersection of radiology and vascular surgery. It is becoming increasingly important that the contemporary vascular surgeon understands this shifting paradigm, as these once-nascent technologies are finally maturing and will be encountered with increasingly regularity in daily clinical practice.","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46777706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contemporary multimodal approach to diagnosis and treatment of vascular graft and endograft infections 诊断和治疗血管移植物和移植物内感染的现代多模式方法
IF 2.5 3区 医学 Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1053/j.semvascsurg.2023.03.006
Lau Røge Jepsen , Karl Sörelius , Reshaabi Srinanthalogen , Jacob Budtz-Lilly

Vascular graft and endograft infections (VGEIs) are a feared complication because of their morbidity, cost, and mortality. Despite broad and varying strategies, as well as limited evidence, societal guidelines do exist. The objective of this review was to supplement current guidelines with emerging and multimodal techniques for treatment. An electronic search was performed using PubMed with specific search terms from 2019 to 2022 in which VGEIs were described or analyzed in the carotid, thoracic aorta, abdominal, or lower extremity arteries. A total of 12 studies were collected from the electronic search. Articles describing all of the anatomic areas were present. The incidence of VGEIs depends on the anatomic location, varying from <1% to 18%. Gram-positive bacteria are the most common organism. Referral of patients with VGEIs to centers of excellence is paramount, as is pathogen identification, preferably from direct sampling techniques. The MAGIC (Management of Aortic Graft Infection Collaboration) criteria have been endorsed for all VGEIs and validated for aortic VGEI. They are well supplemented with additional diagnostic techniques. Treatment must be individualized, although the goal should be the removal of infected material with appropriate revascularization. VGEIs remain a devastating complication, despite changing or improving medical surgical techniques in vascular surgery. Prophylactic measures, early diagnosis, and patient-specific therapy remain the cornerstones of treatment for this feared complication.

血管移植物和移植物内感染(VGEIs)是一种令人担忧的并发症,因为它们的发病率、成本和死亡率。尽管有广泛而多样的战略,也有有限的证据,但社会指导方针确实存在。这篇综述的目的是用新兴的多模式治疗技术来补充现行指南。从2019年到2022年,使用PubMed进行了电子搜索,其中描述或分析了颈动脉、胸主动脉、腹部或下肢动脉中的VGEI。电子检索共收集了12项研究。文章描述了所有的解剖区域。VGEI的发生率取决于解剖位置,从<;1%至18%。革兰氏阳性菌是最常见的生物体。将VGEIs患者转诊到卓越中心至关重要,病原体鉴定也是如此,最好通过直接采样技术。MAGIC(主动脉移植物感染协作管理)标准已被认可用于所有VGEI,并对主动脉VGEI进行了验证。它们得到了额外诊断技术的很好补充。治疗必须是个体化的,尽管目标应该是通过适当的血运重建来清除受感染的物质。VGEIs仍然是一种毁灭性的并发症,尽管改变或改进了血管外科的医疗手术技术。预防措施、早期诊断和针对患者的治疗仍然是治疗这种令人担忧的并发症的基石。
{"title":"Contemporary multimodal approach to diagnosis and treatment of vascular graft and endograft infections","authors":"Lau Røge Jepsen ,&nbsp;Karl Sörelius ,&nbsp;Reshaabi Srinanthalogen ,&nbsp;Jacob Budtz-Lilly","doi":"10.1053/j.semvascsurg.2023.03.006","DOIUrl":"10.1053/j.semvascsurg.2023.03.006","url":null,"abstract":"<div><p>Vascular graft and endograft infections <strong>(</strong>VGEIs) are a feared complication because of their morbidity, cost, and mortality. Despite broad and varying strategies, as well as limited evidence, societal guidelines do exist. The objective of this review was to supplement current guidelines with emerging and multimodal techniques for treatment. An electronic search was performed using PubMed with specific search terms from 2019 to 2022 in which VGEIs were described or analyzed in the carotid, thoracic aorta, abdominal, or lower extremity arteries. A total of 12 studies were collected from the electronic search. Articles describing all of the anatomic areas were present. The incidence of VGEIs depends on the anatomic location, varying from &lt;1% to 18%. Gram-positive bacteria are the most common organism. Referral of patients with VGEIs to centers of excellence is paramount, as is pathogen identification, preferably from direct sampling techniques. The MAGIC (Management of Aortic Graft Infection Collaboration) criteria have been endorsed for all VGEIs and validated for aortic VGEI. They are well supplemented with additional diagnostic techniques. Treatment must be individualized, although the goal should be the removal of infected material with appropriate revascularization. VGEIs remain a devastating complication, despite changing or improving medical surgical techniques in vascular surgery. Prophylactic measures, early diagnosis, and patient-specific therapy remain the cornerstones of treatment for this feared complication.</p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10017418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute ischemia of the upper and lower limbs: Tailoring the treatment to the underlying etiology 上肢和下肢急性缺血:根据潜在病因定制治疗
IF 2.5 3区 医学 Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1053/j.semvascsurg.2023.04.006
Ciro Ferrer, Giulia Antonietta Cannizzaro, Adelaide Borlizzi, Cataldo Caruso, Rocco Giudice

Acute limb ischemia (ALI) can be a devastating clinical emergency with potentially limb- or life-threatening consequences. It is defined as a quickly developing or sudden decrease in limb perfusion producing new or worsening symptoms and signs, often threatening limb viability. ALI is commonly related to an acute arterial occlusion. Rarely, extensive venous occlusion can lead to upper and lower extremities ischemia (ie, phlegmasia). The incidence of acute peripheral arterial occlusion causing ALI is approximately 1.5 cases per 10,000 people per year. The clinical presentation depends on the etiology and whether the patient has underlying peripheral artery disease. Except for traumas, the most common etiologies are embolic or thrombotic events. Peripheral embolism, likely related to embolic heart disease, is the most common cause of acute upper extremity ischemia. However, an acute thrombotic event may occur in native arteries, at the site of a pre-existing atherosclerotic plaque, or as a failure of previous vascular interventions. The presence of an aneurysm may predispose to ALI for both embolic and thrombotic mechanisms. Immediate diagnosis, accurate assessment of limb viability, and prompt intervention, when needed, play important roles in salvaging the affected limb and preventing major amputation. Severity of symptoms is usually dependent on the amount of surrounding arterial collateralization, which may often reflect a pre-existing chronic vascular disease. For this reason, early recognition of the underlying etiology is crucial for choice of best management and definitely for treatment success. Any error in the initial evaluation may negatively affect the functional prognosis of the limb and endanger the patient's life. The aim of this article was to discuss diagnosis, etiology, pathophysiology, and treatment of patients with acute ischemia of the upper and lower limbs.

急性肢体缺血(ALI)可能是一种毁灭性的临床紧急情况,具有潜在的肢体或危及生命的后果。它被定义为肢体灌注迅速发展或突然减少,产生新的或恶化的症状和体征,通常威胁肢体的生存能力。ALI通常与急性动脉闭塞有关。广泛的静脉闭塞很少会导致上下肢缺血(即痰)。急性外周动脉闭塞导致ALI的发生率约为每年每10000人1.5例。临床表现取决于病因以及患者是否有潜在的外周动脉疾病。除了创伤,最常见的病因是栓塞或血栓性事件。外周栓塞可能与栓塞性心脏病有关,是急性上肢缺血最常见的原因。然而,急性血栓性事件可能发生在天然动脉、预先存在的动脉粥样硬化斑块部位,或作为先前血管干预的失败。动脉瘤的存在可能因栓塞和血栓机制而易患急性肺损伤。及时诊断、准确评估肢体的生存能力,并在需要时及时干预,在挽救受影响的肢体和预防重大截肢方面发挥着重要作用。症状的严重程度通常取决于周围动脉侧支循环的数量,这通常反映了预先存在的慢性血管疾病。因此,早期认识潜在的病因对于选择最佳治疗和治疗成功至关重要。初步评估中的任何错误都可能对肢体的功能预后产生负面影响,并危及患者的生命。本文的目的是讨论急性上下肢缺血患者的诊断、病因、病理生理学和治疗。
{"title":"Acute ischemia of the upper and lower limbs: Tailoring the treatment to the underlying etiology","authors":"Ciro Ferrer,&nbsp;Giulia Antonietta Cannizzaro,&nbsp;Adelaide Borlizzi,&nbsp;Cataldo Caruso,&nbsp;Rocco Giudice","doi":"10.1053/j.semvascsurg.2023.04.006","DOIUrl":"10.1053/j.semvascsurg.2023.04.006","url":null,"abstract":"<div><p><span><span>Acute limb ischemia (ALI) can be a devastating clinical emergency with potentially limb- or life-threatening consequences. It is defined as a quickly developing or sudden decrease in </span>limb perfusion<span><span><span> producing new or worsening symptoms and signs, often threatening limb viability. ALI is commonly related to an acute arterial occlusion<span>. Rarely, extensive venous occlusion can lead to upper and </span></span>lower extremities ischemia (ie, phlegmasia). The incidence of acute peripheral arterial occlusion causing ALI is approximately 1.5 cases per 10,000 people per year. The clinical presentation depends on the etiology and whether the patient has underlying </span>peripheral artery disease. Except for traumas, the most common etiologies are embolic or thrombotic events. Peripheral embolism, likely related to embolic heart disease, is the most common cause of acute upper extremity ischemia. However, an acute thrombotic event may occur in native arteries, at the site of a pre-existing atherosclerotic plaque, or as a failure of previous vascular interventions. The presence of an aneurysm may predispose to ALI for both embolic and thrombotic mechanisms. Immediate diagnosis, accurate assessment of limb viability, and prompt intervention, when needed, play important roles in salvaging the affected limb and preventing major amputation. Severity of symptoms is usually dependent on the amount of surrounding arterial </span></span>collateralization<span><span>, which may often reflect a pre-existing chronic vascular disease. For this reason, early recognition of the underlying etiology is crucial for choice of best management and definitely for treatment success. Any error in the initial evaluation may negatively affect the functional prognosis of the limb and endanger the patient's life. The aim of this article was to discuss diagnosis, etiology, </span>pathophysiology, and treatment of patients with acute ischemia of the upper and lower limbs.</span></p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10017421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Ruptured abdominal aorto-iliac aneurysms: Diagnosis, treatment, abdominal compartment syndrome, and role of simulation-based training 腹主动脉-髂动脉瘤破裂:诊断、治疗、腹腔隔室综合征和模拟训练的作用
IF 2.5 3区 医学 Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1053/j.semvascsurg.2023.03.002
Anna-Leonie Menges , Mario D`Oria , Alexander Zimmermann , Philip Dueppers

Ruptured abdominal aortic aneurysms (rAAA), with or without iliac involvement, are a life-threatening scenario with high mortality even after surgical therapy. Several factors have contributed to improving perioperative outcomes in recent years, including the progressive use of endovascular aortic repair (EVAR) and intraoperative balloon occlusion of the aorta, a dedicated treatment algorithm with centralization of care to high-volume centres, and optimized perioperative management protocols. Nowadays, EVAR is applicable in the majority of scenarios even in the emergency setting. Among the factors that influence the postoperative course of rAAA patients, abdominal compartment syndrome (ACS) is a rare but life-threatening complication. As its early clinical diagnosis is often missed but crucial to initiate an emergent surgical decompression therapy, dedicated surveillance protocols and transvesical measurement of the intraabdominal pressure are key for prompt diagnosis and immediate treatment of ACS. Further improvement of rAAA patients’ outcome may be achieved by the implementation of simulation-based training (of both technical and non-technical skills for surgeons as well as all involved healthcare personnel in multidisciplinary teams) and by transfer of all rAAA patients to specialized vascular centres with advanced experience and high caseload.

破裂的腹主动脉瘤(rAAA),无论是否累及髂动脉,即使在手术治疗后,也是一种危及生命的情况,死亡率也很高。近年来,有几个因素有助于改善围手术期的结果,包括逐步使用血管内主动脉修复(EVAR)和术中球囊闭塞主动脉、将护理集中到高容量中心的专用治疗算法,以及优化的围手术期管理方案。如今,EVAR适用于大多数情况,甚至在紧急情况下也是如此。在影响rAAA患者术后病程的因素中,腹腔隔室综合征(ACS)是一种罕见但危及生命的并发症。由于其早期临床诊断经常被遗漏,但对启动紧急手术减压治疗至关重要,因此专门的监测方案和经膀胱测量腹腔内压力是ACS及时诊断和立即治疗的关键。通过实施基于模拟的培训(为外科医生以及多学科团队中的所有相关医护人员提供技术和非技术技能),以及将所有rAAA患者转移到具有高级经验和高工作量的专业血管中心,可以进一步改善rAAA患者的治疗效果。
{"title":"Ruptured abdominal aorto-iliac aneurysms: Diagnosis, treatment, abdominal compartment syndrome, and role of simulation-based training","authors":"Anna-Leonie Menges ,&nbsp;Mario D`Oria ,&nbsp;Alexander Zimmermann ,&nbsp;Philip Dueppers","doi":"10.1053/j.semvascsurg.2023.03.002","DOIUrl":"10.1053/j.semvascsurg.2023.03.002","url":null,"abstract":"<div><p>Ruptured abdominal aortic aneurysms (rAAA), with or without iliac involvement, are a life-threatening scenario with high mortality even after surgical therapy. Several factors have contributed to improving perioperative outcomes in recent years, including the progressive use of endovascular aortic repair (EVAR) and intraoperative balloon occlusion of the aorta, a dedicated treatment algorithm with centralization of care to high-volume centres, and optimized perioperative management protocols. Nowadays, EVAR is applicable in the majority of scenarios even in the emergency setting. Among the factors that influence the postoperative course of rAAA patients, abdominal compartment syndrome (ACS) is a rare but life-threatening complication. As its early clinical diagnosis is often missed but crucial to initiate an emergent surgical decompression therapy, dedicated surveillance protocols and transvesical measurement of the intraabdominal pressure are key for prompt diagnosis and immediate treatment of ACS. Further improvement of rAAA patients’ outcome may be achieved by the implementation of simulation-based training (of both technical and non-technical skills for surgeons as well as all involved healthcare personnel in multidisciplinary teams) and by transfer of all rAAA patients to specialized vascular centres with advanced experience and high caseload.</p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9715754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Potential applications of artificial intelligence (AI) and machine learning (ML) on diagnosis, treatment, outcome prediction to address health care disparities of chronic limb-threatening ischemia (CLTI) 人工智能(AI)和机器学习(ML)在慢性肢体威胁缺血(CLTI)诊断、治疗和预后预测方面的潜在应用
IF 2.5 3区 医学 Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1053/j.semvascsurg.2023.06.003
Amirbehzad Bagheri, Mohammad Dehghan Rouzi, Navid Alemi Koohbanani, M. Mahoor, MG Finco, Myeounggon Lee, B. Najafi, Jayer Chung
Chronic limb-threatening ischemia (CLTI) is the most advanced form of peripheral artery disease. CLTI has an extremely poor prognosis and is associated with considerable risk of major amputation, cardiac morbidity, mortality, and poor quality of life. Early diagnosis and targeted treatment of CLTI is critical for improving patient's prognosis. However, this objective has proven elusive, time-consuming, and challenging due to existing health care disparities among patients. In this article, we reviewed how artificial intelligence (AI) and machine learning (ML) can be helpful to accurately diagnose, improve outcome prediction, and identify disparities in the treatment of CLTI. We demonstrate the importance of AI/ML approaches for management of these patients and how available data could be used for computer-guided interventions. Although AI/ML applications to mitigate health care disparities in CLTI are in their infancy, we also highlighted specific AI/ML methods that show potential for addressing health care disparities in CLTI.
{"title":"Potential applications of artificial intelligence (AI) and machine learning (ML) on diagnosis, treatment, outcome prediction to address health care disparities of chronic limb-threatening ischemia (CLTI)","authors":"Amirbehzad Bagheri, Mohammad Dehghan Rouzi, Navid Alemi Koohbanani, M. Mahoor, MG Finco, Myeounggon Lee, B. Najafi, Jayer Chung","doi":"10.1053/j.semvascsurg.2023.06.003","DOIUrl":"https://doi.org/10.1053/j.semvascsurg.2023.06.003","url":null,"abstract":"Chronic limb-threatening ischemia (CLTI) is the most advanced form of peripheral artery disease. CLTI has an extremely poor prognosis and is associated with considerable risk of major amputation, cardiac morbidity, mortality, and poor quality of life. Early diagnosis and targeted treatment of CLTI is critical for improving patient's prognosis. However, this objective has proven elusive, time-consuming, and challenging due to existing health care disparities among patients. In this article, we reviewed how artificial intelligence (AI) and machine learning (ML) can be helpful to accurately diagnose, improve outcome prediction, and identify disparities in the treatment of CLTI. We demonstrate the importance of AI/ML approaches for management of these patients and how available data could be used for computer-guided interventions. Although AI/ML applications to mitigate health care disparities in CLTI are in their infancy, we also highlighted specific AI/ML methods that show potential for addressing health care disparities in CLTI.","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45834884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Acute venous problems: Integrating medical, surgical, and interventional treatments 急性静脉问题:综合医学、外科和介入治疗
IF 2.5 3区 医学 Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1053/j.semvascsurg.2023.04.013
Daniele Bissacco , Tim J. Mandigers , Silvia Romagnoli , Tiziana Aprea , Chiara Lomazzi , Ilenia D'Alessio , Velio Ascenti , Anna Maria Ierardi , Maurizio Domanin , Valerio Stefano Tolva , Gianpaolo Carrafiello , Santi Trimarchi

“Acute venous problems” refers to a group of disorders that affect the veins and result in sudden and severe symptoms. They can be classified based on the pathological triggering mechanisms, such as thrombosis and/or mechanical compression, and their consequences, including symptoms, signs, and complications. The management and therapeutic approach depend on the severity of the disease, the location, and the involvement of the vein segment.

Although summarizing these conditions can be challenging, the objective of this narrative review was to provide an overview of the most common acute venous problems. This will include an exhaustive yet concise and practical description of each condition. The multidisciplinary approach remains one of the major advantages in dealing with these conditions, maximizing the results and the prevention of complications.

“急性静脉问题”是指一组影响静脉并导致突然和严重症状的疾病。它们可以根据病理触发机制(如血栓形成和/或机械压迫)及其后果(包括症状、体征和并发症)进行分类。管理和治疗方法取决于疾病的严重程度、位置和静脉段的受累情况。尽管总结这些情况可能具有挑战性,但本叙述性综述的目的是概述最常见的急性静脉问题。这将包括对每种情况的详尽但简洁实用的描述。多学科方法仍然是处理这些情况、最大限度地提高结果和预防并发症的主要优势之一。
{"title":"Acute venous problems: Integrating medical, surgical, and interventional treatments","authors":"Daniele Bissacco ,&nbsp;Tim J. Mandigers ,&nbsp;Silvia Romagnoli ,&nbsp;Tiziana Aprea ,&nbsp;Chiara Lomazzi ,&nbsp;Ilenia D'Alessio ,&nbsp;Velio Ascenti ,&nbsp;Anna Maria Ierardi ,&nbsp;Maurizio Domanin ,&nbsp;Valerio Stefano Tolva ,&nbsp;Gianpaolo Carrafiello ,&nbsp;Santi Trimarchi","doi":"10.1053/j.semvascsurg.2023.04.013","DOIUrl":"10.1053/j.semvascsurg.2023.04.013","url":null,"abstract":"<div><p>“Acute venous problems” refers to a group of disorders that affect the veins and result in sudden and severe symptoms. They can be classified based on the pathological triggering mechanisms, such as thrombosis and/or mechanical compression, and their consequences, including symptoms, signs, and complications. The management and therapeutic approach depend on the severity of the disease, the location, and the involvement of the vein segment.</p><p>Although summarizing these conditions can be challenging, the objective of this narrative review was to provide an overview of the most common acute venous problems. This will include an exhaustive yet concise and practical description of each condition. The multidisciplinary approach remains one of the major advantages in dealing with these conditions, maximizing the results and the prevention of complications.</p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9662171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Seminars in Vascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1